Literature DB >> 29478053

Acid-Base and Electrolyte Managements in Chronic Kidney Disease and End-Stage Renal Disease: Case-Based Discussion.

Jing Lin1, Zhen Cheng2, Xiaoqiang Ding1, Qi Qian3.   

Abstract

Acid-base and electrolyte alterations are common in patients with chronic kidney disease (CKD) and end-stage kidney failure (ESRD). The alterations become more complex as CKD advances to ESRD, leading to morbidity and mortality. Three cases are presented illustrating some key prototypic features in CKD and ESRD. Each is accompanied by discussion of pathophysiology, diagnosis, and treatment options. Newer investigational results are integrated into the existing body of knowledge. Although rigorous assessment of various dialysis prescriptions is scanty, in its current state, instituting a well thought-out, multi-pronged management plan to minimize CKD/ESRD and dialysis-related electrolyte and acid-base disruptions is appropriate. There is a pressing need for prospective interventional trials in the future.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic kidney disease; End-stage renal disease; Hemodialysis; Hypoxia; Metabolic acidosis; Metabolic alkalosis

Mesh:

Year:  2018        PMID: 29478053     DOI: 10.1159/000485155

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  End stage renal disease patients undergoing hip fracture surgery have increased length of stay, acute hospital bill size, and reduced survivorship-implications on a bundled care program.

Authors:  Louise Woon Theng Lo; Yanling Xu; Tet Sen Howe; Joyce Suang Bee Koh; Ngai Nung Lo; Youheng Ou Yang
Journal:  Arch Osteoporos       Date:  2022-04-06       Impact factor: 2.617

2.  Assessment of Selected Serum Electrolyte and Associated Risk Factors in Diabetic Patients.

Authors:  Shiferaw Bekele Woyesa; Waqtola Cheneke Gebisa; Delebo Lefebo Anshebo
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-31       Impact factor: 3.168

Review 3.  Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia.

Authors:  Markus Pirklbauer
Journal:  Hemodial Int       Date:  2020-05-20       Impact factor: 1.812

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.